Agenix: Patent In Japan for Diagnostic Technology
Agenix Limited announced that Japan's Patent Office had granted a key patent covering the manufacturing process of its ThromboView® imaging agent for the detection of blood clots in humans.
Agenix Chairman and Chief Executive Officer, Nicholas Weston said, "The granting of patent protection in Japan confers further certainty and significantly increases the commercial value of the ThromboView diagnostic technology globally. In conjunction with the other patents covering the use and production of ThromboView, this new patent delivers a major commercial advantage to Agenix in one of the world's leading markets for diagnostic imaging and manufacturing.”
Japanese Patent Application Number 2003-507139 covers humanized antibodies derived from DD-3B6/22 specific for the D-dimer fragment of fibrin provides long-term protection for the company's technology through broad claims over methods of manufacture and use.
ThromboView is now protected by multiple patents in the Japan, the United States, Europe, Singapore, Australia and New Zealand, with the granting of patents for China and Canada pending. The patents provide protection for ThromboView out to 2022 with possible Hatch-Waxman term extension out to 2027.
- blood clotting
- diagnostic tests
- imaging agents
- 1Groundbreaking experimental method will speed up protein analysis substantially
- 2We are much more unique than assumed
- 3PerkinElmer to acquire EUROIMMUN for approximately $1.3 Billion
- 4Shimadzu acquires specialist for isotope labeled standards
- 5LAUDA appoints Dr. Ralf Hermann as the new General Manager Constant temperature equipment
- 6New three-in-one blood test opens door to precision medicine for prostate cancer
- 7State-of-the-art text mining technologies for chemistry
- 8Eurofins expands its footprint in the Balkan region
- 9New sensors could enable more affordable detection of pollution and diseases
- 10New femto-camera with quadrillion fractions of a second resolution
- Tiny nanoparticles offer significant potential in detecting and treating disease
- New sensors could enable more affordable detection of pollution and diseases
- New femto-camera with quadrillion fractions of a second resolution
- New three-in-one blood test opens door to precision medicine for prostate cancer
- Diamond detectors for CERN